CorMedix Inc CRMD
7.85
0.08
1.03%
as of 25 Sep
- Market cap
- $608.0M
- P/E
- 3.3×
Follow CRMD
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 54.93% | 65.59% | 66.56% | 75.08% |
+8 more TTM periods Free account |
|
| 32.36% | 37.51% | 34.51% | 39.23% | ||
ROIC |
38.84% | 29.97% | 23.38% | 14.02% | |
Return on Tangible Assets |
62.18% | 69.49% | 82.04% | 124.77% | |
Average Days of Receivables |
127.37 | 141.24 | 200.51 | 270.08 | |
Free Cash Flow per Share |
3.19 | 2.45 | 2.40 | 0.98 | |
Free Cash Flow |
250.42 | 194.71 | 172.79 | 74.42 | |
Capital Expenditures |
(3.52) | (2.98) | (2.26) | (0.55) | |
Piotroski F-Score |
4.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
29.44% | 26.01% | 25.06% | 13.04% | |
Accounts Receivable Turnover |
4.53 | 3.82 | 2.80 | 2.44 | |
Accounts Payable Turnover |
9.92 | 7.68 | 7.49 | 1.45 | |
Inventory Turnover |
3.30 | 2.97 | 1.93 | 0.89 | |
Average Days of Payables |
46.94 | 82.62 | 80.02 | 471.67 | |
Days of Inventory on Hand |
176.89 | 197.94 | 301.61 | 666.80 | |
Tax Rate |
(0.08) | (0.02) | 0.09 | 0.53 | |
Research and Development Expense of Revenue |
5.97% | 5.84% | 6.20% | 5.81% | |
Selling, General and Administrative Expense of Revenue |
29.85% | 31.59% | 34.09% | 38.29% | |
Share Based Compensation of Revenue |
3.53% | 3.73% | 4.44% | 5.34% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.36 | 1.09 | 1.07 | 0.46 | |
Depreciation/Fixed assets |
4.60 | 4.18 | 2.58 | 1.03 | |
Capex/Depreciation |
(0.10) | (0.12) | (0.15) | (0.12) | |
Revenue per Share |
5.89 | 5.03 | 4.33 | 2.82 | |
Operating CF per Share |
3.24 | 2.49 | 2.43 | 0.99 | |
Capex per Share |
(0.04) | (0.04) | (0.03) | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 | |
Net Profit Margin |
40.49% | 45.25% | 52.31% | 75.83% |
Columns are period end dates